Combination High Dose Melphalan and Autologous PBSC Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study.
Phase of Trial: Phase I/II
Latest Information Update: 29 Aug 2012
At a glance
- Drugs Bortezomib; Melphalan
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 21 Jun 2011 Actual initiation date changed from Aug 2008 to May 2005 as reported by ClinicalTrials.gov.
- 10 Jan 2011 Actual end date changed from Jul 2009 to Jul 2011 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History